Literature DB >> 11435823

Adrenal sparing surgery during radical nephrectomy in patients with renal cell cancer: a new algorithm.

R Paul1, J Mordhorst, R Busch, H Leyh, R Hartung.   

Abstract

PURPOSE: Ipsilateral adrenalectomy is usually performed during radical nephrectomy because of renal cell cancer. Because renal tumors are detected more often in the earlier stages due to widespread use of ultrasound and computerized tomography, we define a subset of patients who would be eligible for adrenal sparing surgery. In a retrospective analysis we evaluated whether parameters obtained preoperatively are able to predict adrenal metastasis.
MATERIALS AND METHODS: A total of 866 consecutive patients who underwent nephrectomy and ipsilateral adrenalectomy from 1983 to 1999 were evaluated. Preoperative parameters, including tumor size, location, clinical stage, number of tumors, and patient age and sex, were retrospectively compared with the histological results. Univariate and multivariate analyses were performed.
RESULTS: A total of 27 (3.1%) adrenal metastases were noted in the 866 patients, and 63% were on the left side and 37% on the right side. Mean tumor size was 10 cm. with versus 6 cm. without adrenal involvement. Of the 27 patients 21 had multiple metastases at diagnosis and only 6 (0.7% of all 866) presented with solitary ipsilateral adrenal metastasis. Univariate and multivariate analyses revealed tumor size and M stage as best preoperative predictors of adrenal involvement.
CONCLUSIONS: Adrenal sparing surgery is possible, and we suggest a new algorithm. If maximum tumor size measured by computerized tomography is less than 8 cm. and staging examination does not show organ or lymph node metastases, adrenalectomy is not necessary because of oncological reasons. This algorithm has to be validated by a prospective analysis.

Entities:  

Mesh:

Year:  2001        PMID: 11435823

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  11 in total

Review 1.  Chinese guidelines on the management of renal cell carcinoma (2015 edition).

Authors:  Jun Guo; Jianhui Ma; Yan Sun; Shukui Qin; Dingwei Ye; Fangjian Zhou; Zhisong He; Xinan Sheng; Feng Bi; Dengfeng Cao; Yingxia Chen; Yiran Huang; Houjie Liang; Jun Liang; Jiwei Liu; Wenchao Liu; Yueyin Pan; Yongqian Shu; Xin Song; Weibo Wang; Xiuwen Wang; Xiaoan Wu; Xiaodong Xie; Xin Yao; Shiying Yu; Yanqiao Zhang; Aiping Zhou
Journal:  Ann Transl Med       Date:  2015-11

2.  Surgical approach and the use of lymphadenectomy and adrenalectomy among patients undergoing radical nephrectomy for renal cell carcinoma.

Authors:  Christopher P Filson; David C Miller; Joanne S Colt; Julie Ruterbusch; W Marston Linehan; Wong-Ho Chow; Kendra Schwartz
Journal:  Urol Oncol       Date:  2011-03-17       Impact factor: 3.498

3.  Routine adrenalectomy is unnecessary during surgery for large and/or upper pole renal tumors when the adrenal gland is radiographically normal.

Authors:  Alexander Kutikov; Zachary J Piotrowski; Daniel J Canter; Tianyu Li; David Y T Chen; Rosalia Viterbo; Richard E Greenberg; Stephen A Boorjian; Robert G Uzzo
Journal:  J Urol       Date:  2011-02-22       Impact factor: 7.450

Review 4.  Factors influencing adrenal metastasis in renal cell carcinoma.

Authors:  S M Moudouni; I En-nia; A Manunta; F Guillé; B Lobel
Journal:  Int Urol Nephrol       Date:  2003       Impact factor: 2.370

Review 5.  Long-term outcomes of the surgical management of renal cell carcinoma.

Authors:  John S Lam; Arie S Belldegrun; Allan J Pantuck
Journal:  World J Urol       Date:  2006-02-15       Impact factor: 4.226

Review 6.  Improving outcomes in high-risk, nonmetastatic renal cancer: new data and ongoing trials.

Authors:  Chris Blick; Alastair W S Ritchie; Timothy Eisen; Grant D Stewart
Journal:  Nat Rev Urol       Date:  2017-08-01       Impact factor: 14.432

7.  Unadjusted Plasma Renin Activity as a "First-Look" Test to Decide Upon Further Investigations for Primary Aldosteronism.

Authors:  Peter Rye; Alex Chin; Janice Pasieka; Benny So; Adrian Harvey; Gregory Kline
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-03-10       Impact factor: 3.738

8.  Role of surgery in advanced/metastatic renal cell carcinoma.

Authors:  Suresh Bhat
Journal:  Indian J Urol       Date:  2010-04

9.  Staging of renal cell carcinoma: Current concepts.

Authors:  John S Lam; Tobias Klatte; Alberto Breda
Journal:  Indian J Urol       Date:  2009 Oct-Dec

Review 10.  A 25 year perspective on the evolution and advances in an understanding of the biology, evaluation and treatment of kidney cancer.

Authors:  Daniel M Geynisman; Jodi K Maranchie; Mark W Ball; Gennady Bratslavsky; Eric A Singer
Journal:  Urol Oncol       Date:  2021-06-04       Impact factor: 2.954

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.